Impurity Identification and Characterization of some Anti-Diabetic Drugs using various Analytical Methods
By: Vashi, Dhara
.
Contributor(s): Suresh Kumar.
Publisher: Raipur Asian Pharma Press 2019Edition: Vol.9(4), Oct-Dec.Description: 243-248p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Asian journal of pharmaceutical researchSummary: Various regulatory authorities such as the International Conference on Harmonization (ICH), The United States Food and Drug administration (FDA) are emphasizing on the purity requirements and the identification of impurities in Active Pharmaceutical Ingredients (APIs). Now a day research give great exposure to impurity profiling and forced degradation study of Active pharmaceutical ingredient and combined dosage form used for the treatment of Diabetic. Anti- Diabetic drugs class include: Sulfonylureas, Meglitinides, Thiazolidinediones, Alpha-glucosidases inhibitor, Dipeptidyl-peptidase-4 (DPP-4) inhibitors, Glucagon-like peptide-1 (GLP-1) agonist, Sodium glucose co-transporter 2 (SGLT2) inhibitors. As per ICH, Impurity profiling description of the identified and unidentified impurities present in a typical batch of API produced by a specific controlled production process. There are number of Spectroscopic method like UV(Ultraviolet Spectrometry), MS(Mass spectrometry), IR (infrared spectroscopy), NMR(Nuclear magnetic resonance) and Chromatographic methods like HPLC(High performance liquid chromatography), TLC(Thin layer Chromatography), HPTLC(High Performance thin layer chromatography), GC(Gas chromatography) used for identification, isolation and characterization of Impurities present in pharmaceuticals. Various hyphenated techniques are used for identification and better resolution between impurities having near to similar structure with each other or with APIs like Liquid Chromatography (LC)-Mass Spectroscopy (MS), LC-NMR, LC-NMR-MS, GC-MS, and LC-MS. This leads interest of impurity profiling in pharmaceuticals.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2020-2021166 |
Various regulatory authorities such as the International Conference on Harmonization (ICH), The United States Food and Drug administration (FDA) are emphasizing on the purity requirements and the identification of impurities in Active Pharmaceutical Ingredients (APIs). Now a day research give great exposure to impurity profiling and forced degradation study of Active pharmaceutical ingredient and combined dosage form used for the treatment of Diabetic. Anti- Diabetic drugs class include: Sulfonylureas, Meglitinides, Thiazolidinediones, Alpha-glucosidases inhibitor, Dipeptidyl-peptidase-4 (DPP-4) inhibitors, Glucagon-like peptide-1 (GLP-1) agonist, Sodium glucose co-transporter 2 (SGLT2) inhibitors. As per ICH, Impurity profiling description of the identified and unidentified impurities present in a typical batch of API produced by a specific controlled production process. There are number of Spectroscopic method like UV(Ultraviolet Spectrometry), MS(Mass spectrometry), IR (infrared spectroscopy), NMR(Nuclear magnetic resonance) and Chromatographic methods like HPLC(High performance liquid chromatography), TLC(Thin layer Chromatography), HPTLC(High Performance thin layer chromatography), GC(Gas chromatography) used for identification, isolation and characterization of Impurities present in pharmaceuticals. Various hyphenated techniques are used for identification and better resolution between impurities having near to similar structure with each other or with APIs like Liquid Chromatography (LC)-Mass Spectroscopy (MS), LC-NMR, LC-NMR-MS, GC-MS, and LC-MS. This leads interest of impurity profiling in pharmaceuticals.
Click on an image to view it in the image viewer
There are no comments for this item.